- Volumes 108-119 (2025)
-
Volumes 96-107 (2025)
-
Volume 107
Pages 1-376 (December 2025)
-
Volume 106
Pages 1-336 (November 2025)
-
Volume 105
Pages 1-356 (October 2025)
-
Volume 104
Pages 1-332 (September 2025)
-
Volume 103
Pages 1-314 (August 2025)
-
Volume 102
Pages 1-276 (July 2025)
-
Volume 101
Pages 1-166 (June 2025)
-
Volume 100
Pages 1-256 (May 2025)
-
Volume 99
Pages 1-242 (April 2025)
-
Volume 98
Pages 1-288 (March 2025)
-
Volume 97
Pages 1-256 (February 2025)
-
Volume 96
Pages 1-340 (January 2025)
-
Volume 107
-
Volumes 84-95 (2024)
-
Volume 95
Pages 1-392 (December 2024)
-
Volume 94
Pages 1-400 (November 2024)
-
Volume 93
Pages 1-376 (October 2024)
-
Volume 92
Pages 1-316 (September 2024)
-
Volume 91
Pages 1-378 (August 2024)
-
Volume 90
Pages 1-580 (July 2024)
-
Volume 89
Pages 1-278 (June 2024)
-
Volume 88
Pages 1-350 (May 2024)
-
Volume 87
Pages 1-338 (April 2024)
-
Volume 86
Pages 1-312 (March 2024)
-
Volume 85
Pages 1-334 (February 2024)
-
Volume 84
Pages 1-308 (January 2024)
-
Volume 95
-
Volumes 72-83 (2023)
-
Volume 83
Pages 1-258 (December 2023)
-
Volume 82
Pages 1-204 (November 2023)
-
Volume 81
Pages 1-188 (October 2023)
-
Volume 80
Pages 1-202 (September 2023)
-
Volume 79
Pages 1-172 (August 2023)
-
Volume 78
Pages 1-146 (July 2023)
-
Volume 77
Pages 1-152 (June 2023)
-
Volume 76
Pages 1-176 (May 2023)
-
Volume 75
Pages 1-228 (April 2023)
-
Volume 74
Pages 1-200 (March 2023)
-
Volume 73
Pages 1-138 (February 2023)
-
Volume 72
Pages 1-144 (January 2023)
-
Volume 83
-
Volumes 60-71 (2022)
-
Volume 71
Pages 1-108 (December 2022)
-
Volume 70
Pages 1-106 (November 2022)
-
Volume 69
Pages 1-122 (October 2022)
-
Volume 68
Pages 1-124 (September 2022)
-
Volume 67
Pages 1-102 (August 2022)
-
Volume 66
Pages 1-112 (July 2022)
-
Volume 65
Pages 1-138 (June 2022)
-
Volume 64
Pages 1-186 (May 2022)
-
Volume 63
Pages 1-124 (April 2022)
-
Volume 62
Pages 1-104 (March 2022)
-
Volume 61
Pages 1-120 (February 2022)
-
Volume 60
Pages 1-124 (January 2022)
-
Volume 71
- Volumes 54-59 (2021)
- Volumes 48-53 (2020)
- Volumes 42-47 (2019)
- Volumes 36-41 (2018)
- Volumes 30-35 (2017)
- Volumes 24-29 (2016)
- Volumes 18-23 (2015)
- Volumes 12-17 (2014)
- Volume 11 (2013)
- Volume 10 (2012)
- Volume 9 (2011)
- Volume 8 (2010)
- Volume 7 (2009)
- Volume 6 (2008)
- Volume 5 (2007)
- Volume 4 (2006)
- Volume 3 (2005)
- Volume 2 (2004)
- Volume 1 (2003)
• Lopinavir was successfully micronized by SEDS with supercritical CO2, achieving significant particle size reduction and high yield.
• The SEDS process retained the chemical structure and crystalline form of lopinavir with solvent residues meeting ICH standards.
• The micronized product showed greatly improved in vitro dissolution compared with the raw drug.
Lopinavir (LPV) is a key antiviral drug limited in clinical application by its poor water solubility. This study employed solution-enhanced dispersion by supercritical CO2 (SEDS) technology for LPV micronization, and optimized four core process parameters via orthogonal experimental design. Under optimal conditions (15 MPa, 35 °C, 2 mg/mL, 1.2 mL/min), the mean particle size of LPV was reduced from 80.0 μm to 6.6 μm with a micronization yield of 82.5%. Characterizations verified that LPV retained its Type I crystalline form and chemical structure after processing, with residual solvents well below ICH limits. The in vitro dissolution performance was significantly enhanced, reaching 74.0% at 96 h versus 25.1% for raw LPV. This study confirms that SEDS is an efficient green approach for LPV micronization. It effectively improves the drug dissolution property while preserving structural and crystalline integrity, providing a feasible strategy for the formulation development of poorly water-soluble drugs.